Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Anti-Synthetase Syndrome”

11 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 11 of 11 results

Testing effectiveness (Phase 2)Study completedNCT05669014
What this trial is testing

Proof of Concept Study to Evaluate the Efficacy and Safety of Daxdilimab in Participants With Dermatomyositis (DM) or Anti-synthetase Inflammatory Myositis (ASIM)

Who this might be right for
Idiopathic Inflammatory Myositis
Amgen 12
Testing effectiveness (Phase 2)Study completedNCT03215927
What this trial is testing

Abatacept for the Treatment of Myositis-associated Interstitial Lung Disease

Who this might be right for
MyositisInterstitial Lung Disease
Rohit Aggarwal, MD 20
Not applicableUnknownNCT04941547
What this trial is testing

Association Between Cancer and Anti-synthetase Syndrome

Who this might be right for
Antisynthetase Syndrome
Central Hospital, Nancy, France 200
Early research (Phase 1)Looking for participantsNCT07085104
What this trial is testing

Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease

Who this might be right for
Systemic Lupus Erythematosus (With and Without Nephritis)Idiopathic Inflammatory MyopathySystemic Sclerosis
Allogene Therapeutics 66
Large-scale testing (Phase 3)Looking for participantsNCT06154252
What this trial is testing

RESET-Myositis: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Idiopathic Inflammatory Myopathy or Juvenile Idiopathic Inflammatory Myopathy

Who this might be right for
Idiopathic Inflammatory MyopathyDermatomyositisAnti-Synthetase Syndrome+5 more
Cabaletta Bio 74
Testing effectiveness (Phase 2)Study completedNCT00774462
What this trial is testing

Rituximab for the Treatment of Refractory Inflammatory Myopathies and Refractory Myasthenia Gravis

Who this might be right for
MyositisMyasthenia Gravis
Assistance Publique - Hôpitaux de Paris 30
Not applicableLooking for participantsNCT01276470
What this trial is testing

Environmental Risk Factors for the Anti-synthetase Syndrome

Who this might be right for
MyositisDermatomyositisPolymyositis+2 more
National Institute of Environmental Health Sciences (NIEHS) 580
Not applicableLooking for participantsNCT07374107
What this trial is testing

MIHRA - Patient-Rooted Insights for Shaping Myositis Science (PRISMS)

Who this might be right for
IBMIIMMyositis+9 more
Myositis International Health & Research Collaborative Alliance Foundation 700
Testing effectiveness (Phase 2)Looking for participantsNCT06665256
What this trial is testing

Phase 2 Study of Rapcabtagene Autoleucel in Myositis

Who this might be right for
Idiopathic Inflammatory Myopathies
Novartis Pharmaceuticals 123
Early research (Phase 1)Active Not RecruitingNCT06255028
What this trial is testing

CNTY-101 in Participants With Refractory B Cell-mediated Autoimmune Diseases

Who this might be right for
Systemic Lupus ErythematosusLupus NephritisIdiopathic Inflammatory Myopathies+1 more
Century Therapeutics, Inc. 6
Testing effectiveness (Phase 2)Ended earlyNCT05650567
What this trial is testing

Study of M5049 in DM and PM Participants (NEPTUNIA)

Who this might be right for
DermatomyositisPolymyositis
EMD Serono Research & Development Institute, Inc. 40